Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: First report

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 50-54

  Wolach, Baruch ^a,b   Ash, Shifra ^b,c   Gavrieli, Ronit ^a   Stark, Batia ^b,c   Yaniv, Isaac ^b,c   Roos, Dirk ^d  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

ALL; CGD; Molecular analysis; NADPH oxidase; Neutrophils

Indexed keywords

AMINO ACID; NUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERICIDAL ACTIVITY; CASE REPORT; CONVALESCENCE; CYBB GENE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA DETERMINATION; ENZYME SUBUNIT; FRAMESHIFT MUTATION; GENE; GENE INSERTION; GENE MUTATION; GRANULOMATOSIS; HUMAN; IMMUNE DEFICIENCY; INFANT; LEUKOCYTE; MALE; NEUTROPHIL; PRIORITY JOURNAL; RECURRENT INFECTION; STOP CODON; T CELL LEUKEMIA; X CHROMOSOMAL INHERITANCE;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; NADPH OXIDASE; NUCLEAR FAMILY; PEDIGREE; TREATMENT OUTCOME;

EID: 24344433406     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20424     Document Type: Article

References (17)

1. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 2000;79:155-169.
2. Roos D, Curnutte JT. Chronic granulomatous disease. In: Ochs HD, Smith CIE, Puck JM, editors. Primary immunodeficiency diseases. A molecular and genetic approach. New York: Oxford; 1999. p 353-374.
3. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 2000;79:170-200.
4. Babior BM. NADPH oxidase: an update. Blood 1999;93:1464-1476.
5. Heyworth PG, Curnutte JT, Rae J, et al. Hematologically important mutations: X-linked chronic granulomatous disease (second update). Blood Cells Mol Dis 2001;27:16-26.
6. Liese J, Kloos S, Jendrossek V, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000;137:687-693.
7. Cunningham-Rundles C, Cooper DL, Duffy TP, Strauchen J. Lymphomas of mucosa-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol 2002;69:171-178.
8. Mueller N. Overview of the epidemiology of malignancy in immune deficiency. J Acquir Immune Defic Syndr 1999;1:S5-S10.
9. Weel EA, Redekop WK, Weening RS. Increased risk of malignancy for patients with chronic granulomatous disease and its possible link to the pathogenesis of cancer. Eur J Cancer 1996;32A:734-735.
10. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest Suppl 1968;21:77-89.
11. Weisbart RH, Golde DW, Gasson JC. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol 1986;137:3584-3587.
12. Clawson CC, Repine JE. Quantitation of maximal bactericidal capability in human neutrophils. J Lab Clin Med 1976;88:316-327.
13. 558 of human neutrophils. Blood 1989;73:1686-1694.
14. de Boer M, Bakker E, Van Lierde S, Roos D. Somatic triple mosaicism in a carrier of X-linked chronic granulomatous disease. Blood 1998;91:252-257.
15. Weitberg AB, Weitzman SA, Clark EP, Stossel TP. Effects of antioxidants in oxidant-induced sister chromatid exchange formation. J Clin Invest 1985;75:1835-1841.
16. Weitzman SA, Stossel TP. Mutation caused by human phagocytes. Science 1981;212:546-547.
17. Weitberg AB, Weitzman SA, Destrempes M, Latt SA, Stossel TP. Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N Engl J Med 1983;308:26-30.